Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why [Yahoo! Finance]
Instil Bio, Inc. (TIL)
NASDAQ:AMEX Investor Relations:
nasdaq.com/symbol/til
Company Research
Source: Yahoo! Finance
Instil is engaged in developing tumor infiltrating lymphocyte, or TIL, therapies targeting multiple cancer indications. Earlier this week, the company entered into an agreement with an unknown collaborator who will conduct preclinical manufacturing feasibility studies on its ITIL-306, a next-generation, genetically engineered TIL therapy, which is being developed for treating multiple solid tumors. Per the company, the collaborator has already started the feasibility studies on ITIL-306, and if successful, it may begin an investigator-initiated clinical study aimed at enrolling patients with non-small cell lung cancer (NSCLC) in China. Image Source: Zacks Investment Research Concurrently, Instil announced that it has decided to close its UK manufacturing facility and clinical operations to save costs. This is likely to be completed by the first half of 2024. This could have been one of the factors driving the stock's rise in the said time frame. Apart from NSCLC, ITIL-306
Show less
Read more
Impact Snapshot
Event Time:
TIL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TIL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TIL alerts
High impacting Instil Bio, Inc. news events
Weekly update
A roundup of the hottest topics
TIL
News
- What Makes Instil Bio (TIL) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateGlobeNewswire
TIL
Earnings
- 11/13/23 - Miss
TIL
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- TIL's page on the SEC website